Company

Ribon Therapeutics, Inc.

Ribon Therapeutics, Inc. is a Cambridge, US biotechnology company developing small molecule therapies, mainly in oncology.

About

Founded in 2015 and headquartered in Cambridge, US, Ribon Therapeutics, Inc. was founded by W Kraus and develops small molecule therapies for cancer and other diseases, with its first small molecule programs in oncology. On December 22, 2022, it raised USD 25.00 mn in Series B funding from Pfizer Inc., bringing its total raised to USD 25.00 mn at a valuation of USD 250.26 mn. Prakash Raman and Victoria Richon serve as executive leaders, and the company has completed five deals.

3Funding rounds

10Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in